New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PharmaCielo Ltd.
PCLOF
Shape
US Flag

OTC

Unprofitable

EPS improving

Unprofitable

EPS improving

9M

Drug Manufacturers - Specialty & Generic

0.05USD

Shape0.01 ( 37.05%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-80%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

67%
OverviewChart

Quote Panel

Shape
Updated July 4, 2025
1W 13.36 % 1M 29.47 % 3M 11.82 % 1Y -55.99 %

Key Metrics

Shape

  • Market Cap

    9.24M

  • Shares Outstanding

    187.83M

  • Share in Float

    171.23M

  • Dividende

    0

  • Earning Date

    No Data

  • Price Target

    0.0492

  • Average Volume

    31365

  • Beta

    1.714

  • Range

    0.024-0.15

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Website

    https://www.pharmacielo.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

PCLOF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.02
vs -0.02

Q2.23

arrow
arrow

N/A

-0.02
vs -0.02

Q3.23

arrow
arrow

N/A

-0.01
vs -0.03

Q4.23

arrow
arrow

N/A

-0.03
vs -0.01

Q1.24

arrow
arrow

N/A

-0.01
vs -0.02

Q2.24

arrow
arrow

N/A

-0.01
vs -0.02

Q3.24

arrow
arrow

N/A

-0.01
vs -0.01

Q4.24

arrow
arrow

N/A

-0.01
vs -0.03

Q1.25

arrow
arrow

N/A

-0.10
vs -0.01

Q2.25

arrow
arrow

N/A

-0.05
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-35%

786.5K  vs 1.2M

Q2.23

arrow
arrow

-92%

159.5K  vs 2.1M

Q3.23

arrow
arrow

-26%

351.7K  vs 475.3K

Q4.23

arrow
arrow

-84%

244K  vs 1.5M

Q1.24

arrow
arrow

-69%

240.3K  vs 786.5K

Q2.24

arrow
arrow

+391%

783.7K  vs 159.5K

Q3.24

arrow
arrow

+278%

1.3M  vs 351.7K

Q4.24

arrow
arrow

+362%

1.1M  vs 244K

Q1.25

arrow
arrow

+193%

703.7K  vs 240.3K

Q2.25

arrow
arrow

-82%

139.8K  vs 783.7K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-81%

-0.81
vs -0.66

Q2.23

arrow
arrow

-101%

-1.01
vs -0.81

Q3.23

arrow
arrow

-99%

-0.99
vs -1.01

Q4.23

arrow
arrow

+381%

3.81
vs -0.99

Q1.24

arrow
arrow

+72%

0.72
vs 3.81

Q2.24

arrow
arrow

+47%

0.47
vs 0.72

Q3.24

arrow
arrow

+35%

0.35
vs 0.47

Q4.24

arrow
arrow

+20%

0.2
vs 0.35

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Reports Q4 2024 Financial Results
PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing
PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Reports Q3 2024 Financial Results
PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024
PCLOF

newsfilecorp.com

12 hours ago

PharmaCielo Announces Intention to Extend Expiry Date of Warrants
PCLOF

newsfilecorp.com

16 hours ago

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024